Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

MAYNE PHARMA Aktie

>MAYNE PHARMA Performance
1 Woche: -1,6%
1 Monat: -9,1%
3 Monate: -25,9%
6 Monate: -60,0%
1 Jahr: -71,4%
laufendes Jahr: -25,9%
>MAYNE PHARMA Aktie
Name:  MAYNE PHARMA GROUP LTD.
Land:  Australien
Sektor:  Gesundheit
ISIN/ Wkn:  AU000000MYX0 / A1C821
Symbol/ Ticker:  HG6 (Frankfurt)
Kürzel:  FRA:HG6, ETR:HG6, HG6:GR
Index:  -
Webseite:  http://www.maynepharma.co..
Profil:  Mayne Pharma Group Ltd. is a specialty pharmaceutical company focused on the development, manufacture, and commercialization of branded and generic pharmaceutical products. Headquartered in Salisbury, Australia, the company operates globally with key..
>Volltext..
Marktkapitalisierung:  116.13 Mio. EUR
Unternehmenswert:  101.75 Mio. EUR
Umsatz:  235.33 Mio. EUR
EBITDA:  13.43 Mio. EUR
Nettogewinn:  -48.11 Mio. EUR
Gewinn je Aktie:  -0.59 EUR
Schulden:  24.55 Mio. EUR
Liquide Mittel:  38.93 Mio. EUR
Operativer Cashflow:  13.83 Mio. EUR
Bargeldquote:  0.26
Umsatzwachstum:  6.18%
Gewinnwachstum:  30.54%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Div. Historie:  18.01.23 - 6.0656006€
03.03.11 - 1.5764872€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  MAYNE PHARMA
Letzte Datenerhebung:  04.04.26
>MAYNE PHARMA Kennzahlen
Aktien/ Unternehmen:
Aktien: 81.25 Mio. St.
Frei handelbar: 85.53%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: -
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Strong buy
Kursziel: 144.74%
Bewertung:
KGV: -
KGV lG: -
KUV: 0.47
KBV: 0.57
PEG-Ratio: -
EV/EBITDA: 7.57
Rentabilität:
Bruttomarge: 46.85%
Gewinnmarge: -20.19%
Operative Marge: -11.63%
Managementeffizenz:
Gesamtkaprendite: -7.94%
Eigenkaprendite: -20.58%
>MAYNE PHARMA Peer Group
Gesundheit
 
25.03.26 - 22:12
Mayne Pharma growth strategy in Women′s health - ASX SMIDcaps Conference (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
25.03.26 - 17:24
Mayne Pharma Growth Strategy in Women′s Health (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
23.02.26 - 01:01
Earnings Call: Mayne Pharma steigert Bruttomarge im ersten Halbjahr 2026 (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.12.25 - 05:24
Mayne Pharma signals short-term pain as it resets for growth (Fool)
 
It has been a turbulent year for Mayne Pharma after the terminated takeover bid by US company Cosette Pharmaceuticals. The post Mayne Pharma signals short-term pain as it resets for growth appeared first on The Motley Fool Australia....
12.12.25 - 00:03
Termination of Proposed Acquisition of Mayne Pharma (Business Wire)
 
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a notice on Mayne Pharma Group Limited (Mayne Pharma, ASX: Ticker MYX) terminating the agreement between Cosette and Mayne Pharma under which Cosette was to acquire all the outstanding shares of Mayne Pharma (Scheme Implementation Deed). Cosette also notes the announcements from Mayne Pharma on 10 December 2025 and 11 December 2025 and confirms that on 11 December 2025 Mayne Pharma served its own notice of termination of the Scheme Implementation Deed on Cosette. Both parties' notices of termination follow a ruling from the Treasurer of Australia blocking the proposed transaction and the expiry of the end date under the Scheme Implementation Deed in November. Cosette strongly rejects Mayne Pharma's claims that it has breached the Scheme Implementation Deed and believes Mayne Pharma's 10 December and 11 December ASX announcements c...
04.12.25 - 00:00
Doomed takeover bid for Mayne Pharma to come to an end (Fool)
 
The Mayne Pharma takeover saga appears to be finally drawing to an end, with shareholders bearing the pain of the ill-fated deal. The post Doomed takeover bid for Mayne Pharma to come to an end appeared first on The Motley Fool Australia....
24.11.25 - 20:15
XFRA: Deletion of Instruments from Boerse Frankfurt - 24.11.2025 (XETRA)
 
The following instruments on Boerse Frankfurt do have their last trading day on 24.11.2025 Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.11.2025 ISIN Name DE0005220909 NEXUS AG O.N. AU000000MYX0 MAYNE PHARMA GROUP LTD. BMG5210S1061 JOY CITY PPTY HD -,10 CA98956K1030 0749116 B C LTD, CH1305603651 PHOENIX MEC. 2.LINIE SF 1 NL0015000AG6 LAVA THERAP. B.V. EO-,12 SE0014401121 SUBGEN AI AB SE0015221619 BACKAHEDEN FASTIGHETS AB US5904791358 MESA AIR GROUP INC US92719V1008 VIMEO INC. DL-,01 XS2036387525 ARDAGH P.F./ 19/26 REGS KYG9430L1077 WANGUO GOLD GROUP...
24.11.25 - 04:00
Why Accent Group, EOS, Mayne Pharma, and Pilbara Minerals shares are falling today (Fool)
 
These shares are starting the week in the red. But why? The post Why Accent Group, EOS, Mayne Pharma, and Pilbara Minerals shares are falling today appeared first on The Motley Fool Australia....
21.11.25 - 02:00
Australia Blocks U.S.-Based Cosette’s $387.2 Million Takeover of Mayne Pharma (WSJ EN)
 
Australia's government said it would block a $387.2 million takeover of Mayne Pharma by U.S. company Cosette Pharmaceuticals on national security grounds, citing a need to protect critical medical supply chains....
10.11.25 - 07:48
Markets in a Minute: Antipa shines, Mayne Pharma sinks (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
10.11.25 - 04:00
Why Alliance Aviation, Brainchip, Mayne Pharma, and Perpetual Credit shares are sinking today (Fool)
 
These shares are starting the week in the red. But why? The post Why Alliance Aviation, Brainchip, Mayne Pharma, and Perpetual Credit shares are sinking today appeared first on The Motley Fool Australia....
31.10.25 - 02:30
Mayne Pharma plummets -30% as foreign review board rejects Cosette buyout (Market Herald)
 
Mayne Pharma (ASX:MYX) has revealed a letter from Australian Treasurer Jim Chalmers,…...
31.10.25 - 02:12
Why Aeris Resources, Humm, Mayne Pharma, and Steadfast shares are sinking today (Fool)
 
These shares are ending the week in the red. But why? The post Why Aeris Resources, Humm, Mayne Pharma, and Steadfast shares are sinking today appeared first on The Motley Fool Australia....
16.10.25 - 05:12
Why AMP, GQG, Jumbo, and Mayne Pharma shares are racing higher today (Fool)
 
These shares are having a strong session on Thursday. But why? The post Why AMP, GQG, Jumbo, and Mayne Pharma shares are racing higher today appeared first on The Motley Fool Australia....
16.10.25 - 02:48
Here€s a potential double-digit trade gain, following Mayne Pharma€s takeover court win (Fool)
 
A once-stalled takeover deal for Mayne Pharma still represents value for traders. The post Here's a potential double-digit trade gain, following Mayne Pharma's takeover court win appeared first on The Motley Fool Australia....
08.09.25 - 06:12
Why Mayne Pharma, Metal Powder Works, Smartgroup, and Super Retail shares are dropping today (Fool)
 
These shares are starting the week in the red. But why? The post Why Mayne Pharma, Metal Powder Works, Smartgroup, and Super Retail shares are dropping today appeared first on The Motley Fool Australia....
04.06.25 - 04:00
Why Coronado, DroneShield, Lovisa, and Mayne Pharma shares are racing higher today (Fool)
 
These shares are having a good time on hump day. But why? The post Why Coronado, DroneShield, Lovisa, and Mayne Pharma shares are racing higher today appeared first on The Motley Fool Australia....
23.05.25 - 06:36
Why ARB, Block, Mayne Pharma, and Paladin Energy shares are charging higher today (Fool)
 
These shares are having a strong finish to the week. But why? The post Why ARB, Block, Mayne Pharma, and Paladin Energy shares are charging higher today appeared first on The Motley Fool Australia....
22.05.25 - 07:30
Mayne Pharma nosedive deepens as Cosette mulls scrapping $672M buy-up (Market Herald)
 
Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets…...
22.05.25 - 04:48
Why Dexus, Mayne Pharma, Nufarm, and Treasury Wine shares are falling today (Fool)
 
These shares are having a tough session on Thursday. But why? The post Why Dexus, Mayne Pharma, Nufarm, and Treasury Wine shares are falling today appeared first on The Motley Fool Australia....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!